Research ArticleCancer Immunotherapy

CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients

See allHide authors and affiliations

Science Translational Medicine  16 May 2012:
Vol. 4, Issue 134, pp. 134ra62
DOI: 10.1126/scitranslmed.3003330

Log in to view PDF

Log in through your institution

Log in through your institution